{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:41:01Z","timestamp":1773373261889,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s43440-020-00167-2","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T06:02:47Z","timestamp":1603087367000},"page":"172-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies"],"prefix":"10.1007","volume":"73","author":[{"given":"Maria Maddalena","family":"Cavalluzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Budriesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"De Salvia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Quintieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Piarulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gualtiero","family":"Milani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Gualdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-1531","authenticated-orcid":false,"given":"Matteo","family":"Micucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Viale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Lentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"167_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(05)70139-0","volume":"5","author":"SS Al-Abri","year":"2005","unstructured":"Al-Abri SS, Beeching NJ, Nye FJ. Traveller's diarrhoea. Lancet Infect Dis. 2005;5:349\u201360.","journal-title":"Lancet Infect Dis"},{"key":"167_CR2","first-page":"358","volume":"92","author":"TL Switaj","year":"2015","unstructured":"Switaj TL, Winter KJ, Christensen SR. Diagnosis and management of foodborne illness. Am Fam Physician. 2015;92:358\u201365.","journal-title":"Am Fam Physician"},{"key":"167_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4155\/fsoa-2016-0023","volume":"2","author":"OA Odeyemi","year":"2016","unstructured":"Odeyemi OA, Sani NA. Antibiotic resistance and burden of foodborne diseases in developing countries. Future Sci. 2016;2:139.","journal-title":"Future Sci"},{"key":"167_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3389\/fmicb.2019.01509","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang Y, Feye KM, Shi Z, Pavlidis HO, Kogut M, Ashworth JA, et al. Historical review on antibiotic resistance of foodborne Campylobacter. Front Microbiol. 2019;10:1509.","journal-title":"Front Microbiol"},{"key":"167_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.15171\/apb.2019.041","volume":"9","author":"F Hashempour-Baltork","year":"2019","unstructured":"Hashempour-Baltork F, Hosseini H, Shojaee-Aliabadi S, Torbati M, Alizadeh AM, Alizadeh M. Drug resistance and the prevention strategies in food borne bacteria: an update review. Adv Pharm Bull. 2019;9:335\u201347.","journal-title":"Adv Pharm Bull"},{"key":"167_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.4315\/0362-028X-66.4.700","volume":"66","author":"DA Barber","year":"2003","unstructured":"Barber DA, Miller GY, McNamara PE. Models of antimicrobial resistance and foodborne illness: examining assumptions and practical applications. J Food Prot. 2003;66:700\u20139.","journal-title":"J Food Prot"},{"key":"167_CR7","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/nmo.12979","volume":"28","author":"IM Fuentes","year":"2016","unstructured":"Fuentes IM, Christianson JA. Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome. Neurogastroenterol Motil. 2016;28:1613\u20138.","journal-title":"Neurogastroenterol Motil"},{"key":"167_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.5056\/jnm15061","volume":"21","author":"M Radulovic","year":"2015","unstructured":"Radulovic M, Anand P, Korsten MA, Gong B. Targeting ion channels: an important therapeutic implication in gastrointestinal dysmotility in patients with spinal cord injury. J Neurogastroenterol Motil. 2015;21:494\u2013502.","journal-title":"J Neurogastroenterol Motil"},{"key":"167_CR9","doi-asserted-by":"crossref","unstructured":"Rajendran VM, Schulzke J-D, Seidler UE. Chapter 58\u2014ion channels of the gastrointestinal epithelial cells. In: Said HM, editor. Physiology of the gastrointestinal tract. 6th ed. Academic Press; 2018. p. 1363\u20131404.","DOI":"10.1016\/B978-0-12-809954-4.00058-X"},{"key":"167_CR10","doi-asserted-by":"publisher","first-page":"210B","DOI":"10.1016\/0002-9149(85)90633-2","volume":"55","author":"DO Castell","year":"1985","unstructured":"Castell DO. Calcium-channel blocking agents for gastrointestinal disorders. Am J Cardiol. 1985;55:210B\u20133B.","journal-title":"Am J Cardiol"},{"key":"167_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1124\/pr.114.009654","volume":"67","author":"GW Zamponi","year":"2015","unstructured":"Zamponi GW, Striessnig J, Koschak A, Dolphin AC. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev. 2015;67:821\u201370.","journal-title":"Pharmacol Rev"},{"key":"167_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2017.00286","volume":"8","author":"T Godfraind","year":"2017","unstructured":"Godfraind T. Discovery and development of calcium channel blockers. Front Pharmacol. 2017;8:286.","journal-title":"Front Pharmacol"},{"key":"167_CR13","doi-asserted-by":"publisher","first-page":"G506","DOI":"10.1152\/ajpgi.00051.2015","volume":"309","author":"L Neshatian","year":"2015","unstructured":"Neshatian L, Strege PR, Rhee P-L, Kraichely RE, Mazzone A, Bernard CE, et al. Ranolazine inhibits voltage-gated mechanosensitive sodium channels in human colon circular smooth muscle cells. Am J Physiol Gastrointest Liver Physiol. 2015;309:G506\u2013G512512.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"167_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1756283X11415892","volume":"5","author":"A Beyder","year":"2012","unstructured":"Beyder A, Farrugia G. Targeting ion channels for the treatment of gastrointestinal motility disorders. Therap Adv Gastroenterol. 2012;5:5\u201321.","journal-title":"Therap Adv Gastroenterol"},{"key":"167_CR15","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1161\/01.STR.31.11.2543","volume":"31","author":"HC Diener","year":"2000","unstructured":"Diener HC, Cortens M, Ford G, Grotta J, Hacke W, Kaste M, et al. Lubeluzole in acute ischemic stroke treatment: a double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke. 2000;31:2543\u201351.","journal-title":"Stroke"},{"key":"167_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1124\/mol.112.080804","volume":"83","author":"J-F Desaphy","year":"2013","unstructured":"Desaphy J-F, Carbonara R, Costanza T, Lentini G, Cavalluzzi MM, Bruno C, et al. Molecular dissection of lubeluzole use-dependent block of voltage-gated sodium channels discloses new therapeutic potentials. Mol Pharmacol. 2013;83:406\u201315.","journal-title":"Mol Pharmacol"},{"key":"167_CR17","first-page":"531","volume":"295","author":"R Marrannes","year":"2000","unstructured":"Marrannes R, De Prins E. Site of action of lubeluzole on voltage-sensitive Ca(2+) channels in isolated dorsal root ganglion cells of the rat: influence of pH. J Pharmacol Exp Ther. 2000;295:531\u201345.","journal-title":"J Pharmacol Exp Ther"},{"key":"167_CR18","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1159\/000488169","volume":"45","author":"R Gualdani","year":"2018","unstructured":"Gualdani R, Cavalluzzi MM, Tadini-Buoninsegni F, Convertino M, Gailly P, Stary-Weinzinger A, et al. Molecular insights into hERG potassium channel blockade by lubeluzole. Cell Physiol Biochem. 2018;45:2233\u201345.","journal-title":"Cell Physiol Biochem"},{"key":"167_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejmech.2016.03.045","volume":"116","author":"C Bruno","year":"2016","unstructured":"Bruno C, Cavalluzzi MM, Rusciano MR, Lovece A, Carrieri A, Pracella R, et al. The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca(2+)\/calmodulin-dependent kinase II. Eur J Med Chem. 2016;116:36\u201345.","journal-title":"Eur J Med Chem"},{"key":"167_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4314\/tjpr.v9i3.56284","volume":"9","author":"S Hadji-nejad","year":"2010","unstructured":"Hadji-nejad S, Rahbar M, Mehrgan H. Synergy between phenothiazines and oxacillin against clinical isolates of methicillin-resistant Staphylococcus aureus. Trop J Pharm Res. 2010;9:243\u20139.","journal-title":"Trop J Pharm Res"},{"key":"167_CR21","doi-asserted-by":"publisher","first-page":"35835","DOI":"10.1038\/srep35835","volume":"6","author":"DM Czyz","year":"2016","unstructured":"Czyz DM, Jain-Gupta N, Shuman HA, Crosson SA. A dual-targeting approach to inhibit Brucella abortus replication in human cells. Sci Rep. 2016;6:35835.","journal-title":"Sci Rep"},{"key":"167_CR22","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1128\/JB.182.17.4856-4861.2000","volume":"182","author":"LS Tisa","year":"2000","unstructured":"Tisa LS, Sekelsky JJ, Adler J. Effects of organic antagonists of Ca(2+), Na(+), and K(+) on chemotaxis and motility of Escherichia coli. J Bacteriol. 2000;182:4856\u201361.","journal-title":"J Bacteriol"},{"key":"167_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0014-5793(88)80072-3","volume":"236","author":"T Matsushita","year":"1988","unstructured":"Matsushita T, Hirata H, Kusaka I. Calcium channel blockers inhibit bacterial chemotaxis. FEBS Lett. 1988;236:437\u201340.","journal-title":"FEBS Lett"},{"key":"167_CR24","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/jhet.3282","volume":"55","author":"R Bala","year":"2018","unstructured":"Bala R, Kumari P, Sood S, Kumar V, Singh N, Singh K. Phthaloyl dichloride DMF mediated synthesis of benzothiazole-based 4-formylpyrazole derivatives: studies on their antimicrobial and antioxidant activities. J Heterocycl Chem. 2018;55:2507\u201315.","journal-title":"J Heterocycl Chem"},{"key":"167_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijantimicag.2012.10.009","volume":"41","author":"Q Yu","year":"2013","unstructured":"Yu Q, Ding X, Xu N, Cheng X, Qian K, Zhang B, et al. In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms. Int J Antimicrob Agents. 2013;41:179\u201382.","journal-title":"Int J Antimicrob Agents"},{"key":"167_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2217\/fmb-2018-0277","volume":"14","author":"KR Caleffi-Ferracioli","year":"2019","unstructured":"Caleffi-Ferracioli KR, Cardoso RF, de Souza JV, Murase LS, Canezin PH, Scodro RB, Siqueira VL, Pavan FR. Modulatory effects of verapamil in rifampicin activity against Mycobacterium tuberculosis. Future Microbiol. 2019;14:185\u201394.","journal-title":"Future Microbiol"},{"key":"167_CR27","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.2174\/092986712802884204","volume":"19","author":"E Carosati","year":"2012","unstructured":"Carosati E, Ioan P, Micucci M, Broccatelli F, Cruciani G, Zhorov BS, et al. 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets. Curr Med Chem. 2012;19:4306\u201323.","journal-title":"Curr Med Chem"},{"key":"167_CR28","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/molecules25051056","volume":"25","author":"M Micucci","year":"2020","unstructured":"Micucci M, Viale M, Chiarini A, Spinelli D, Frosini M, Tavani C, et al. 3-Aryl-4-nitrobenzothiochromans S, S-dioxide: from calcium-channel modulators properties to multidrug-resistance reverting activity. Molecules. 2020;25:1056.","journal-title":"Molecules"},{"key":"167_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/chir.20240","volume":"18","author":"C Bruno","year":"2006","unstructured":"Bruno C, Carocci A, Catalano A, Cavalluzzi MM, Corbo F, Franchini C, et al. Facile, alternative route to Lubeluzole, its enantiomer, and the racemate. Chirality. 2006;18:227\u201331.","journal-title":"Chirality"},{"key":"167_CR30","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1016\/j.bmcl.2013.06.077","volume":"23","author":"MM Cavalluzzi","year":"2013","unstructured":"Cavalluzzi MM, Viale M, Bruno C, Carocci A, Catalano A, Carrieri A, et al. A convenient synthesis of lubeluzole and its enantiomer: evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells. Bioorg Med Chem Lett. 2013;23:4820\u20133.","journal-title":"Bioorg Med Chem Lett"},{"key":"167_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.mpmed.2019.03.004","volume":"47","author":"P Kelly","year":"2019","unstructured":"Kelly P. Infectious diarrhoea. Medicine. 2019;47:341\u20136.","journal-title":"Medicine"},{"key":"167_CR32","doi-asserted-by":"crossref","unstructured":"Andersen BM. Gastrointestinal infections. In: Prevention and control of infections in hospitals. Cham: Springer; 2019. p. 745\u201354.","DOI":"10.1007\/978-3-319-99921-0_52"},{"key":"167_CR33","unstructured":"EUCAST. Disk diffusion method for antimicrobial susceptibility testing\u2014Version 6.0. 2017. www.eucast.org."},{"key":"167_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/biomedicines6020070","volume":"6","author":"L Caputo","year":"2018","unstructured":"Caputo L, Quintieri L, Cavalluzzi MM, Lentini G, Habtemariam S. Antimicrobial and antibiofilm activities of citrus water-extracts obtained by microwave-assisted and conventional methods. Biomedicines. 2018;6:70.","journal-title":"Biomedicines"},{"key":"167_CR35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nchembio.559","volume":"7","author":"L Ejim","year":"2011","unstructured":"Ejim L, Farha MA, Falconer SB, Wildenhain J, Coombes BK, Tyers M, et al. Combinations of antibiotics and non-antibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol. 2011;7:348\u201350.","journal-title":"Nat Chem Biol"},{"key":"167_CR36","unstructured":"CLSI (Clinical and Laboratory Standards Institute). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. M07-A9, Approved Standard - Tenth Edition 2010, vol 32, No 14. Wayne (USA) Laboratory Standards."},{"key":"167_CR37","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","volume":"40","author":"RL White","year":"1996","unstructured":"White RL, Burgess DS, Manduru M, Bosso JA. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother. 1996;40:1914\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"167_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-2362.2001.00810.x","volume":"31","author":"D Mitolo-Chieppa","year":"2001","unstructured":"Mitolo-Chieppa D, Mansi G, Nacci C, De Salvia MA, Montagnani M, Potenza MA, et al. Idiopathic chronic constipation: tachykinins as cotransmitters in colonic contraction. Eur J Clin Invest. 2001;31:349\u201355.","journal-title":"Eur J Clin Invest"},{"key":"167_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/jmf.2015.0072","volume":"19","author":"M Micucci","year":"2016","unstructured":"Micucci M, Angeletti A, Cont M, Corazza I, Aldini R, Donadio E, et al. Flowers and Olea europea L leaves extract-based formulation for hypertension care: in vitro efficacy and toxicological profile. J Med Food. 2016;19:504\u201312.","journal-title":"J Med Food"},{"key":"167_CR40","volume-title":"Manual of pharmacologic calculations with computer programs","author":"RJ Tallarida","year":"1987","unstructured":"Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs. 2nd ed. New York: Springer-Verlag; 1987.","edition":"2"},{"key":"167_CR41","doi-asserted-by":"crossref","unstructured":"Motulsky H., A. Christopoulos. Fitting models to biological data using linear and non linear regression. San Diego:GraphPad Software Inc.; 2003. www.graphpad.com.","DOI":"10.1093\/oso\/9780195171792.001.0001"},{"key":"167_CR42","unstructured":"Motulsky HJ. Prism 5 statistics guide. San Diego: GraphPad Software Inc.; 2007. www.graphpad.com."},{"key":"167_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/jac\/20.1.123","volume":"20","author":"JA Hoogkamp-Korstanje","year":"1987","unstructured":"Hoogkamp-Korstanje JA. Antibiotics in Yersinia enterocolitica infections. J Antimicrob Chemother. 1987;20:123\u201331.","journal-title":"J Antimicrob Chemother"},{"key":"167_CR44","doi-asserted-by":"publisher","first-page":"e0005216","DOI":"10.1371\/journal.pntd.0005216","volume":"11","author":"D Saraka","year":"2017","unstructured":"Saraka D, Savin C, Kouassi S, Ciss\u00e9 B, Koffi E, Cabanel N, et al. Yersinia enterocolitica, a neglected cause of human enteric infections in C\u00f4te d'Ivoire. PLoS Negl Trop Dis. 2017;11:e0005216.","journal-title":"PLoS Negl Trop Dis"},{"key":"167_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12223-009-0037-2","volume":"54","author":"KG Torkar","year":"2009","unstructured":"Torkar KG, Seme K. Antimicrobial susceptibility, beta-lactamase and enterotoxin production in Bacillus cereus isolates from clinical and food samples. Folia Microbiol. 2009;54:233\u20138.","journal-title":"Folia Microbiol"},{"key":"167_CR46","unstructured":"Kramer JM, Gilbert RJ. Bacillus cereus and other Bacillus. In: Foodborne bacterial pathogens. New York: Marcel Dekker; 1989. p. 21\u201370."},{"key":"167_CR47","first-page":"180","volume":"89","author":"W Barr","year":"2014","unstructured":"Barr W, Smith A. Acute diarrhea. Am Fam Physician. 2014;89:180\u20139.","journal-title":"Am Fam Physician"},{"key":"167_CR48","first-page":"1962","volume":"92","author":"HL Du Pont","year":"1997","unstructured":"Du Pont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997;92:1962\u201375.","journal-title":"Am J Gastroenterol"},{"key":"167_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1254\/jjp.28.873","volume":"28","author":"O Yagasaki","year":"1978","unstructured":"Yagasaki O, Suzuki H, Sohji Y. Effects of loperamide on acetylcholine and prostaglandin elease fromisolated guinea pig ileum. Japan J Pharmacol. 1978;28:8\u2013882.","journal-title":"Japan J Pharmacol"},{"key":"167_CR50","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1021\/jm0604373","volume":"49","author":"E Carosati","year":"2006","unstructured":"Carosati E, Cruciani G, Chiarini A, Budriesi R, Ioan P, Spisani R, et al. Calcium channel antagonists discovered by a multidisciplinary approach. J Med Chem. 2006;49:5206\u201316.","journal-title":"J Med Chem"},{"key":"167_CR51","first-page":"S11","volume":"7","author":"DE Baker","year":"2007","unstructured":"Baker DE. Loperamide: a pharmacological review. Rev Gastroenterol Disord. 2007;7:S11\u2013S18.","journal-title":"Rev Gastroenterol Disord"},{"key":"167_CR52","doi-asserted-by":"publisher","first-page":"e1800141","DOI":"10.1002\/ardp.201800141","volume":"351","author":"HAA Ezelarab","year":"2018","unstructured":"Ezelarab HAA, Abbas SH, Hassan HA, Abuo-Rahma GEA. Recent updates of fluoroquinolones as antibacterial agents. Arch Pharm Chem Life Sci. 2018;351:e1800141.","journal-title":"Arch Pharm Chem Life Sci"},{"key":"167_CR53","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1128\/AAC.00922-07","volume":"52","author":"KE Bowker","year":"2008","unstructured":"Bowker KE, Noel AR, MacGowan AP. Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model. Antimicrob Agents Chemother. 2008;52:4370\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"167_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/01.STR.27.1.76","volume":"27","author":"HC Diener","year":"1996","unstructured":"Diener HC, Hacke W, Hennerici M, R\u00e5dberg J, Hantson L, De Keyser J. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group. Stroke. 1996;27:76\u201381.","journal-title":"Stroke"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00167-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-020-00167-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00167-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T02:20:45Z","timestamp":1723774845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-020-00167-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1007\/s43440-020-00167-2","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"27 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}